Cargando…

The Selective Autophagy Receptor Optineurin in Crohn’s Disease

Autophagy is a pathway that allows cells to target organelles, protein complexes, or invading microorganisms for lysosomal degradation. The specificity of autophagic processes is becoming increasingly recognized and is conferred by selective autophagy receptors such as Optineurin (OPTN). As an autop...

Descripción completa

Detalles Bibliográficos
Autores principales: Tschurtschenthaler, Markus, Adolph, Timon Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902526/
https://www.ncbi.nlm.nih.gov/pubmed/29692785
http://dx.doi.org/10.3389/fimmu.2018.00766
_version_ 1783314770502352896
author Tschurtschenthaler, Markus
Adolph, Timon Erik
author_facet Tschurtschenthaler, Markus
Adolph, Timon Erik
author_sort Tschurtschenthaler, Markus
collection PubMed
description Autophagy is a pathway that allows cells to target organelles, protein complexes, or invading microorganisms for lysosomal degradation. The specificity of autophagic processes is becoming increasingly recognized and is conferred by selective autophagy receptors such as Optineurin (OPTN). As an autophagy receptor, OPTN controls the clearance of Salmonella infection and mediates mitochondrial turnover. Recent studies demonstrated that OPTN is critically required for pathogen clearance and an appropriate cytokine response in macrophages. Moreover, OPTN emerges as a critical regulator of inflammation emanating from epithelial cells in the intestine. OPTN directly interacts with and promotes the removal of inositol-requiring enzyme 1α, a central inflammatory signaling hub of the stressed endoplasmic reticulum (ER). Perturbations of ER and autophagy functions have been linked to inflammatory bowel disease (IBD) and specifically Crohn’s disease. Collectively, these studies may explain how perturbations at the ER can be resolved by selective autophagy to restrain inflammatory processes in the intestine and turn the spotlight on OPTN as a key autophagy receptor. This review covers a timely perspective on the regulation and function of OPTN in health and IBD.
format Online
Article
Text
id pubmed-5902526
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-59025262018-04-24 The Selective Autophagy Receptor Optineurin in Crohn’s Disease Tschurtschenthaler, Markus Adolph, Timon Erik Front Immunol Immunology Autophagy is a pathway that allows cells to target organelles, protein complexes, or invading microorganisms for lysosomal degradation. The specificity of autophagic processes is becoming increasingly recognized and is conferred by selective autophagy receptors such as Optineurin (OPTN). As an autophagy receptor, OPTN controls the clearance of Salmonella infection and mediates mitochondrial turnover. Recent studies demonstrated that OPTN is critically required for pathogen clearance and an appropriate cytokine response in macrophages. Moreover, OPTN emerges as a critical regulator of inflammation emanating from epithelial cells in the intestine. OPTN directly interacts with and promotes the removal of inositol-requiring enzyme 1α, a central inflammatory signaling hub of the stressed endoplasmic reticulum (ER). Perturbations of ER and autophagy functions have been linked to inflammatory bowel disease (IBD) and specifically Crohn’s disease. Collectively, these studies may explain how perturbations at the ER can be resolved by selective autophagy to restrain inflammatory processes in the intestine and turn the spotlight on OPTN as a key autophagy receptor. This review covers a timely perspective on the regulation and function of OPTN in health and IBD. Frontiers Media S.A. 2018-04-10 /pmc/articles/PMC5902526/ /pubmed/29692785 http://dx.doi.org/10.3389/fimmu.2018.00766 Text en Copyright © 2018 Tschurtschenthaler and Adolph. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Tschurtschenthaler, Markus
Adolph, Timon Erik
The Selective Autophagy Receptor Optineurin in Crohn’s Disease
title The Selective Autophagy Receptor Optineurin in Crohn’s Disease
title_full The Selective Autophagy Receptor Optineurin in Crohn’s Disease
title_fullStr The Selective Autophagy Receptor Optineurin in Crohn’s Disease
title_full_unstemmed The Selective Autophagy Receptor Optineurin in Crohn’s Disease
title_short The Selective Autophagy Receptor Optineurin in Crohn’s Disease
title_sort selective autophagy receptor optineurin in crohn’s disease
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902526/
https://www.ncbi.nlm.nih.gov/pubmed/29692785
http://dx.doi.org/10.3389/fimmu.2018.00766
work_keys_str_mv AT tschurtschenthalermarkus theselectiveautophagyreceptoroptineurinincrohnsdisease
AT adolphtimonerik theselectiveautophagyreceptoroptineurinincrohnsdisease
AT tschurtschenthalermarkus selectiveautophagyreceptoroptineurinincrohnsdisease
AT adolphtimonerik selectiveautophagyreceptoroptineurinincrohnsdisease